Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes

PLoS ONE 8(2)

Article 2013 English

Related publications

Rebecca C. Coll, Luke O'neill

PLoS ONE

Rebecca C. Coll, Luke O'neill

PLoS ONE

Trudy McGarry, Mary Coerver- Connolly, Rebecca C. Coll, Avril A. B. Robertson, Matthew A. Cooper, Luke O'neill, Douglas J. Veale, Ursula Fearon

Arthritis & Rheumatism

Trudy McGarry, Mary Coerver- Connolly, Rebecca C. Coll, Avril A. B. Robertson, Matthew A. Cooper, Luke O'neill, Douglas J. Veale, Ursula Fearon

Arthritis & Rheumatism

Colin Dempsey, Rebecca C. Coll, Avril A. B. Robertson, Matthew A. Cooper, Luke O'neill, Marina A. Lynch

Journal of Neuroimmunology